AIM grew out of an innovative disease mapping breakthrough that was supported by American Leprosy Missions in partnership with the London School of Hygiene and Tropical Medicine as well as the Ministry of Health in Ghana. Using routine surveillance data of existing cases and morbidity, AIM partners with Ministries of Health, NGOs and others to map cases of neglected tropical diseases (NTDs), enabling more accurately targeted delivery of health services.
AIM combines this innovative mapping method with support for integrated strategic planning and highly targeted case management that helps to better identify at-risk groups, reduce disability, and improve disease control. Our approach is designed to increase access to health services for people living with an NTD, enable disease elimination and increase early detection through combined NTD programs for case management.
AIM is a collaboration that brings together diverse partners including endemic country governments, research institutions, private sector, donors, and non-government organizations to accelerate integrated management of NTDs. American Leprosy Missions is the founding partner of AIM.